DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026) Certified by Founder
Lodge
Synnovation Therapeutics
start up
United States
- Wilmington, DE
- 18/01/2024
- Unknown
- $70,000,000
Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.
We are dedicated to the discovery and development of first-in-class and best-in-class therapeutics that can improve the lives of people with cancer. Leveraging our deep expertise in medicinal chemistry, cancer biology and patient-focused precision medicine, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.
- Industry Pharmaceutical Manufacturing
- Website https://www.synnovationtx.com/
- LinkedIn https://www.linkedin.com/company/synnovationtx/about/
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)